Literature DB >> 1508581

Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data.

U Bick1, C Müller-Leisse, J Tröger, G Jorch, N Roos, J Meyer zu Wendischhoff, U Flothmann, W Kachel, P Lemburg, O Linderkamp.   

Abstract

As part of a multicenter surfactant rescue study, the chest X-rays of 239 preterm and term infants were analyzed. To study the influence of surfactant administration on radiographic appearance, 130 patients with a clinical and radiological diagnosis of typical respiratory distress syndrome were selected, in whom adequate chest x-rays before and within 48 h after treatment were available. Median gestational age was 30 weeks (range 25-38 weeks), median birth weight was 1335 g (range 625-3450). The time of surfactant application ranged between 90 min and 24 h after birth (median 6 h). The most common finding after surfactant administration was uniform (n = 47) or disproportionate (n = 46) improvement of pulmonary aeration, which showed a significant correlation to posttreatment reduction of oxygen requirement (p less than 0.0001). Asymmetric clearance was more often localized on the right side and usually disappeared within two to five days. Only in 13 patients no change of ventilation was found. Development of interstitial emphysema (n = 24, including three patients with pneumothorax) after surfactant treatment was an unfavourable prognostic sign. 54% of these patients (13 of 24) died within the first month of life, compared to 8% (7 of 93) in the group of patients with initial improvement of ventilation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508581     DOI: 10.1007/bf02012487

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  24 in total

1.  Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.

Authors: 
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

2.  Acute and protracted effects of intratracheal surfactant application on internal carotid blood flow velocity, blood pressure and carbondioxide tension in very low birth weight infants.

Authors:  G Jorch; H Rabe; M Garbe; E Michel; L Gortner
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

3.  The effect of reconstituted bovine surfactant on pulmonary mechanics in infants with respiratory distress syndrome.

Authors:  M Tamura; T Kawano
Journal:  Acta Paediatr Jpn       Date:  1989-12

Review 4.  Pulmonary surfactant: physiology, pharmacology and clinical uses.

Authors:  N S Morton
Journal:  Br J Hosp Med       Date:  1989-07

5.  Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.

Authors:  E A Clarke; R L Siegle; A K Gong
Journal:  AJR Am J Roentgenol       Date:  1989-10       Impact factor: 3.959

6.  Varying roentgenographic patterns of patent ductus arteriosus in the newborn.

Authors:  R L Wesenberg; R E Wax; R D Zachman
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1972-02

7.  Patent ductus arteriosus in preterm infants with idiopathic respiratory distress syndrome. Radiographic and echocardiographic evaluation.

Authors:  C B Higgins; J Rausch; W F Friedman; M J Hirschklau; S E Kirkpatrick; T G Goergen; R T Reinke
Journal:  Radiology       Date:  1977-07       Impact factor: 11.105

8.  Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA.

Authors:  M Konishi; T Fujiwara; T Naito; Y Takeuchi; Y Ogawa; K Inukai; M Fujimura; H Nakamura; T Hashimoto
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

9.  Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study.

Authors:  O Hjalmarson
Journal:  Acta Paediatr Scand       Date:  1981-11

10.  A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.

Authors:  J D Horbar; R F Soll; J M Sutherland; U Kotagal; A G Philip; D L Kessler; G A Little; W H Edwards; D Vidyasagar; T N Raju
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

View more
  2 in total

1.  The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems?

Authors:  L E Swischuk; B P Shetty; S D John
Journal:  Pediatr Radiol       Date:  1996

2.  Individualized lung recruitment during high-frequency ventilation in preterm infants is not associated with lung hyperinflation and air leaks.

Authors:  Anne P De Jaegere; Eline E Deurloo; Rick R van Rijn; Martin Offringa; Anton H van Kaam
Journal:  Eur J Pediatr       Date:  2016-06-21       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.